Literature DB >> 19870768

THE DEMONSTRATION OF LESIONS AND VIRUS IN THE LUNGS OF MICE RECEIVING LARGE INTRA-PERITONEAL INOCULATIONS OF EPIDEMIC INFLUENZA VIRUS.

E R Rickard1, T Francis.   

Abstract

Following the intraperitoneal inoculation of mice with large doses of epidemic influenza virus (50,000 to 1 million intranasal M.L.D.) it can be recovered from the lungs in high concentration, and pulmonary lesions of moderate extent may be observed. The virus reaches its highest titer in the lungs 48 to 72 hours after intraperitoneal injection and may persist for 10 days. Virus may be recovered from the blood in the first 24 hours, but is readily detected in the omentum and peritoneum for 5 to 6 days. Mice which as a result of the intraperitoneal injection of virus show a high concentration of virus in the lungs do not die but become solidly immune to intranasal infection. Moreover, as early as 24 to 48 hours after intraperitoneal inoculation of large amounts of virus the animals may exhibit resistance to infection with fatal doses of virus given intranasally. Influenza virus given intravenously to mice is rapidly removed from the blood but persists in the lungs and induces pulmonary lesions. Virus can also be recovered from the liver for several days. With subcutaneous inoculation of influenza virus, however, the virus does not reach the blood or lungs in detectable amounts although the regional lymph nodes may yield considerable quantities of the agent. A brief consideration is presented of the mechanisms of infection and resistance which may be involved.

Entities:  

Year:  1938        PMID: 19870768      PMCID: PMC2133638          DOI: 10.1084/jem.67.6.953

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  CULTIVATION OF HUMAN INFLUENZA VIRUS IN AN ARTIFICIAL MEDIUM.

Authors:  T Francis; T P Magill
Journal:  Science       Date:  1935-10-11       Impact factor: 47.728

2.  TRANSMISSION OF INFLUENZA BY A FILTERABLE VIRUS.

Authors:  T Francis
Journal:  Science       Date:  1934-11-16       Impact factor: 47.728

3.  STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM.

Authors:  T P Magill; T Francis
Journal:  J Exp Med       Date:  1936-05-31       Impact factor: 14.307

4.  THE ANTIBODY RESPONSE OF HUMAN SUBJECTS VACCINATED WITH THE VIRUS OF HUMAN INFLUENZA.

Authors:  T Francis; T P Magill
Journal:  J Exp Med       Date:  1937-01-31       Impact factor: 14.307

5.  THE PRESERVATION OF VIRULENT TREPONEMA PALLIDUM AND TREPONEMA PERTENUE IN THE FROZEN STATE; WITH A NOTE ON THE PRESERVATION OF FILTRABLE VIRUSES.

Authors:  T B Turner
Journal:  J Exp Med       Date:  1938-01-01       Impact factor: 14.307

  5 in total
  3 in total

1.  QUANTITATIVE RELATIONSHIPS BETWEEN THE IMMUNIZING DOSE OF EPIDEMIC INFLUENZA VIRUS AND THE RESULTANT IMMUNITY.

Authors:  T Francis
Journal:  J Exp Med       Date:  1939-01-31       Impact factor: 14.307

2.  STUDIES ON THE TOXICITY OF INFLUENZA VIRUSES : II. THE EFFECT OF INTRA-ABDOMINAL AND INTRAVENOUS INJECTION OF INFLUENZA VIRUSES.

Authors:  W Henle; G Henle
Journal:  J Exp Med       Date:  1946-11-30       Impact factor: 14.307

3.  Studies on the pathogenesis of influenzal pneumonitis; intranasal vs. intravenous infection of mice.

Authors:  R R WAGNER
Journal:  Yale J Biol Med       Date:  1956-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.